Childhood Grade 2 Meningioma — Trials

Childhood Grade 2 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00326664	AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors	completed	Phase 1	55	National Cancer Institute (NCI)NIH	1	Mar 7, 2016	clinicaltrials
NCT00946335	ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors	completed	Phase 1	31	National Cancer Institute (NCI)NIH	1	Jul 9, 2014	clinicaltrials
NCT00052780	Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors	completed	Phase 1	72	National Cancer Institute (NCI)NIH	1	Sep 30, 2013	clinicaltrials
NCT00063973	Cilengitide in Treating Children With Refractory Primary Brain Tumors

Data updated 22 days agoSource updated Mar 7, 2016source: clinicaltrials